The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Authors

  • Andreas Carus Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
  • Karin Holmsten Department of Oncology, Capio Saint Göran Hospital, Stockholm, Sweden;c Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden
  • Helle Pappot Department of Oncology, Rigshopitalet, University Hospital of Copenhagen, Copenhagen, Denmark
  • Anders Ullén Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Solna, Sweden

DOI:

https://doi.org/10.1080/0284186X.2022.2153620

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2022-12-02

How to Cite

Carus, A., Holmsten, K., Pappot, H., & Ullén, A. (2022). The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?. Acta Oncologica, 61(12), 1515–1516. https://doi.org/10.1080/0284186X.2022.2153620

Issue

Vol. 61 No. 12 (2022): Acta Oncologica

Section

Articles